Diazyme's Heart-Type Fatty Acid Binding Protein (H-FABP) Assay is a convenient dual vial liquid stable assay ideal for analyzers which require two part reagent systems. The assay provides a fast, accurate and cost effective method. Accurate and reliable, the assay features excellent correlation with a linear range up to 120 ng/mL and a Within-Run %CV value < 3.6%.
| Product | Catalog Number | Format | Method |
|---|---|---|---|
| Kit | DZ785A | R1/R2 (Dual Vial Liquid Stable) | Dual Vial Liquid Stable, Immunoturbidimetric |
| Calibrator | DZ785A-CAL | Cal: 5 Level | |
| Control | DZ785A-CON | Con: 2 Level |
Product Features
Diazyme's Heart-Type Fatty Acid Binding Protein (H-FABP) Assay is a convenient dual vial liquid stable assay ideal for analyzers which require two part reagent systems. The assay provides a fast, accurate and cost effective method. Accurate and reliable, the assay features excellent correlation with a linear range up to 120 ng/mL and a Within-Run %CV value < 3.6%.
Downloads
Assay Principle
Diazyme's H-FABP Assay is based on a latex enhanced immunoturbidimetric assay. H-FABP in the sample binds to the specific anti H-FABP antibodies, which are coated on latex particles, and causes agglutination. The degree of the turbidity caused by agglutination can be measured optically and is proportional to the amount of H-FABP in the sample. The instrument calculates the H-FABP con-centration of a patient specimen by interpolation of the obtained signal of a 6-point calibration curve.
Intended use
The Diazyme Heart-type Fatty Acid-Binding Protein (H-FABP) Assay is for the determination of heart-type fatty acid-binding protein concentration in serum or lithium-heparin plasma by latex enhanced immunoturbidimetric method. For Research Use Only in the USA.
Regulatory Status
